Sionna Therapeutics Investor Relations Material

Sionna Therapeutics Inc is a biotechnology company focused on the research and development of therapies targeting genetic diseases. The company specializes in discovering small molecule treatments designed to modulate protein function and address the underlying causes of certain conditions. Sionna Therapeutics conducts preclinical and clinical research to advance its pipeline of drug candidates, primarily in the area of rare and inherited disorders. The company collaborates with research institutions and healthcare partners to support its development efforts. Sionna Therapeutics Inc is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.